Parvati B. Patel
Daiichi Sankyo (United States)(US)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19
Most-Cited Works
- → Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis(2018)76 cited
- → Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials(2021)72 cited
- → Hospitalizations due to preventable adverse reactions—a systematic review(2016)68 cited
- → Incidence of Adverse Drug Reactions in Indian Hospitals: A Systematic Review of Prospective Studies(2015)64 cited
- → Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials(2017)45 cited
- → Students’ Perception on Online Teaching and Learning during COVID-19 Pandemic in Medical Education(2021)36 cited
- → Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC(2024)35 cited
- → Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials(2021)29 cited
- → Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review(2020)28 cited
- → Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis(2019)27 cited